MHAN moves, GERS popular, CVSL stumbles

Posted on Monday, January 10th, 2011

Manhattan Pharmaceuticals Inc. (OTCBB: MHAN) skyrocketed 341.2 percent Monday to 7.5 cents. Volume for the stock was 1.68 million, compared to a mere 57,892 shares on average, on word that the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S.

Greenshift Corp. (OTCBB: GERS) traded in 122.01 million shares, nearly double its daily average. Shares traded at one-100ths of a cent, or half of where they closed Friday. GERS develops and commercializes clean technologies designed to address the financial and environmental needs of its clients by decreasing raw material needs.

Cardio Vascular Medical Device Corp. (OTCBB: CVSL) went for a dive of 57.22 percent Monday afternoon to eight-10ths of a cent. Volume for the stock was 382,400 shares, compared to its usual volume of 35,474 shares. The business plan of CVSL is to develop a medical device application utilizing a patent pertaining to a maneuverable coiled guidewire.

Tags: , , , , , , , ,

Leave a Reply